Targets

Advanced Filter

Filter by Group

Filter by Market Availability

Displaying targets 181 - 210 of 27838 in total
Drug NameTypeName
Abciximab
target
Integrin alpha-IIbDetails
Abciximab
target
VitronectinDetails
Abciximab
target
Integrin beta-3Details
Abciximab
target
Low affinity immunoglobulin gamma Fc region receptor II-aDetails
Drotrecogin alfa
target
ProthrombinDetails
Drotrecogin alfa
target
Platelet factor 4Details
Drotrecogin alfa
target
Serpin B6Details
Drotrecogin alfa
target
Coagulation factor VIIIDetails
Drotrecogin alfa
target
ThrombomodulinDetails
Drotrecogin alfa
target
Plasma serine protease inhibitorDetails
Drotrecogin alfa
target
Endothelial protein C receptorDetails
Drotrecogin alfa
target
Coagulation factor VDetails
Drotrecogin alfa
target
Plasminogen activator inhibitor 1Details
Drotrecogin alfa
target
Vitamin K-dependent protein SDetails
Gemtuzumab ozogamicin
target
Myeloid cell surface antigen CD33Details
Gemtuzumab ozogamicin
target
Low affinity immunoglobulin gamma Fc region receptor III-ADetails
Gemtuzumab ozogamicin
target
Low affinity immunoglobulin gamma Fc region receptor III-BDetails
Gemtuzumab ozogamicin
target
High affinity immunoglobulin gamma Fc receptor IDetails
Indium In-111 satumomab pendetide
target
Tumor-associated glycoprotein 72 (TAG-72)Details
Alpha-1-proteinase inhibitor
target
Neutrophil elastaseDetails
Pegaspargase
target
L-asparagineDetails
Pegaspargase
carrier
Thyroxine-binding globulinDetails
Interferon beta-1a
enzyme
Cytochrome P450 1A2Details
Interferon beta-1a
target
Interferon alpha/beta receptor 1Details
Interferon beta-1a
target
Interferon alpha/beta receptor 2Details
Pegademase
target
AdenosineDetails
Pegademase
target
Growth factor receptor-bound protein 2Details
Albumin human
target
Nitric oxideDetails
Eptifibatide
target
Integrin beta-3Details
Infliximab
target
Tumor necrosis factorDetails
Displaying targets 181 - 210 of 27838 in total